"At Ascension St. Vincent Cancer Care on the Ascension St. Vincent Indianapolis campus, our doctors and nurses listen to understand your questions and concerns and provide answers to your questions. Then we deliver a care plan with cancer-fighting treatments and support programs. Our medical, radiation and surgical oncologists, oncology-certified nurses, palliative care specialists, genetic counselors, dietitians, and rehabilitation therapists focus on your needs. We’re dedicated to helping you defeat cancer."

During the past decade, Saint Vincent Oncology Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 11 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Vincent Oncology Center" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Radiation Therapy Oncology Group" with 4 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Wake Forest University Health Sciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Vincent Oncology Center" #1 collaborator was "NRG Oncology" with 10 trials as a collaborator, "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Cooperative Trials Group for Neuro-Oncology" with 1 trials as a collaborator, "Medical Research Council" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Saint Vincent Oncology Center" are "Endometrial Adenocarcinoma" (3 trials), "Endometrial Clear Cell Adenocarcinoma" (3 trials), "Recurrent Uterine Corpus Carcinoma" (3 trials), "Recurrent Uterine Corpus Sarcoma" (3 trials) and "Brain and Central Nervous System Tumors" (2 trials). Many other conditions were trialed in "Saint Vincent Oncology Center" in a lesser frequency.

Most popular intervention types in "Saint Vincent Oncology Center" are "Drug" (12 trials), "Other" (9 trials), "Radiation" (4 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (5 trials), "Bevacizumab" (2 trials), "Docetaxel" (2 trials), "Paclitaxel" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saint Vincent Oncology Center" are 9 trials for "Female" genders and 6 trials for "All" genders.

Currently, there are NaN active trials in "Saint Vincent Oncology Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Saint Vincent Oncology Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Vincent Oncology Center, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".